- Home
- CAPR vs MNMD Comparison
CAPR vs MNMD Comparison
Compare CAPR & MNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAPR
- MNMD
- Stock Information
- Founded
- CAPR 2005
- MNMD 2019
- Country
- CAPR United States
- MNMD United States
- Employees
- CAPR N/A
- MNMD N/A
- Industry
- CAPR Biotechnology: Biological Products (No Diagnostic Substances)
- MNMD Pharmaceuticals and Biotechnology
- Sector
- CAPR Health Care
- MNMD Health Care
- Exchange
- CAPR Nasdaq
- MNMD Nasdaq
- Market Cap
- CAPR 578.4M
- MNMD 524.7M
- IPO Year
- CAPR N/A
- MNMD N/A
- Fundamental
- Price
- CAPR $14.06
- MNMD $7.18
- Analyst Decision
- CAPR Strong Buy
- MNMD Strong Buy
- Analyst Count
- CAPR 7
- MNMD 9
- Target Price
- CAPR $39.29
- MNMD $28.75
- AVG Volume (30 Days)
- CAPR 1.1M
- MNMD 1.4M
- Earning Date
- CAPR 02-27-2025
- MNMD 02-26-2025
- Dividend Yield
- CAPR N/A
- MNMD N/A
- EPS Growth
- CAPR N/A
- MNMD N/A
- EPS
- CAPR N/A
- MNMD N/A
- Revenue
- CAPR $23,228,045.00
- MNMD N/A
- Revenue This Year
- CAPR N/A
- MNMD N/A
- Revenue Next Year
- CAPR $74.85
- MNMD N/A
- P/E Ratio
- CAPR N/A
- MNMD N/A
- Revenue Growth
- CAPR 65.33
- MNMD N/A
- 52 Week Low
- CAPR $3.52
- MNMD $3.50
- 52 Week High
- CAPR $23.40
- MNMD $12.22
- Technical
- Relative Strength Index (RSI)
- CAPR 48.54
- MNMD 50.89
- Support Level
- CAPR $12.31
- MNMD $6.23
- Resistance Level
- CAPR $16.17
- MNMD $7.04
- Average True Range (ATR)
- CAPR 0.82
- MNMD 0.62
- MACD
- CAPR 0.11
- MNMD -0.01
- Stochastic Oscillator
- CAPR 45.34
- MNMD 36.54
About CAPR Capricor Therapeutics Inc.
Capricor Therapeutics Inc is a biotechnology company focused on advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat and prevent a wide range of diseases with targeted delivery.
About MNMD Mind Medicine (MindMed) Inc.
Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.